Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,963,770 | 1,621,040 | 1,408,570 | 1,729,850 | 1,443,080 |
| Marketable Securities | 313,920 | 199,540 | 221,200 | 271,260 | 333,500 |
| Receivables | 1,705,720 | 1,326,750 | 1,482,600 | 1,632,140 | 1,772,340 |
| Inventories | 1,871,610 | 1,810,710 | 1,737,750 | 1,893,360 | 1,866,270 |
| Other current assets | 98,510 | 479,020 | 165,900 | 198,990 | 68,100 |
| TOTAL | $5,953,530 | $5,437,060 | $5,016,020 | $5,725,600 | $5,483,290 |
| Non-Current Assets | |||||
| Investments And Advances | 31,290 | 31,090 | 28,350 | 43,730 | 38,780 |
| Other Non-Current Assets | 494,000 | 473,510 | 471,800 | 527,550 | 570,430 |
| TOTAL | $525,290 | $504,600 | $500,150 | $571,280 | $609,210 |
| Total Assets | $10,097,080 | $9,372,890 | $8,785,870 | $9,968,790 | $9,895,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 295,100 | 303,610 | 305,200 | 449,350 | 306,830 |
| Accrued Expenses | 217,530 | 138,080 | 61,950 | 111,690 | 255,530 |
| Other current liabilities | 1,926,910 | 1,757,120 | 1,853,600 | 1,728,870 | 1,762,850 |
| TOTAL | $2,483,520 | $2,281,670 | $2,474,670 | $2,552,720 | $2,487,830 |
| Non-Current Liabilities | |||||
| Long Term Debt | 184,890 | 179,050 | 176,750 | 193,060 | 196,740 |
| aiOther Non-Current Liabilities | 274,360 | 246,360 | 236,600 | 252,550 | 263,000 |
| TOTAL | $917,740 | $856,870 | $825,820 | $919,190 | $909,190 |
| Total Liabilities | $3,401,280 | $3,138,560 | $3,300,500 | $3,471,920 | $3,397,030 |
| Shareholders' Equity | |||||
| Common Shares | 119,040 | 113,390 | 110,950 | 124,890 | 128,060 |
| Retained earnings | 6,444,480 | 6,103,190 | 5,545,920 | 6,586,300 | 6,452,080 |
| Other shareholders' equity | 137,280 | 21,740 | -166,500 | -209,330 | -76,200 |
| TOTAL | $6,695,800 | $6,234,320 | $5,485,370 | $6,496,860 | $6,498,940 |
| Total Liabilities And Equity | $10,097,080 | $9,372,880 | $8,785,870 | $9,968,780 | $9,895,970 |